Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Biotechnology · China · 2024-02-02

Processing Time
103 days
Decision Date
2024-02-02
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to lead oncology projects focusing on organoid platforms and high-throughput screening to identify new immuno-oncology drug candidates. Her work utilizes three-dimensional organoid models and epigenetic profiling to investigate mechanisms of stemness in cancer stem cells and the role of necroptosis in disease progression. The goal is to identify therapeutic targets that curb tumor growth and enhance immune responses for personalized cancer medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor of improving cancer therapies and advancing stem cell biology was found to have significant national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 500+ citations and publications in top-tier journals like PNAS demonstrated she is well-positioned.

3 Waiver Benefit Met

On balance, the U.S. would benefit from waiving the labor certification to allow this scientist to continue her NIH-aligned research.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 9 peer-reviewed journal articles and patent disclosures in top venues like Molecular Cell and PNAS. She accumulated over 500 citations, with five papers ranking in the top 10% of their field, and completed at least 7 peer reviews. The case demonstrated alignment with NIH-funded research and satisfied all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
California 612 days 2025-08-21
The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-02-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 103 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist